Observational study BOTOX in patients with chronic migraine.
Research type
Research Study
Full title
A 24-month, Prospective, Non-interventional Study to Describe the Long Term, Real-Life Use of BOTOX® for the symptomatic treatment of Adults with Chronic Migraine, Measuring Healthcare Resource Utilization, and Patient Reported Outcomes Observed in Practice.
IRAS ID
145910
Contact name
Fayyaz Ahmed
Contact email
Sponsor organisation
Allergan Pharmaceutical Ireland
Research summary
This is a prospective, non-interventional, observational, open-label study of patients with chronic migraine who have been prescribed BOTOX®. The objective of the study is to describe the long term, real-life use of BOTOX® for adults with chronic migraine (CM) over a two year period, to measure healthcare resource utilization and patient reported outcomes and to record adverse reactions observed in practice. All procedures are performed at the discretion of the participating physicians according to their clinical judgment and the local standard of medical care. It is planned to recruit approximately 1400 patients into the study during a recruitment period of approximately 6-12 months. Patients’ involvement in the study will last 24 months. The total study duration is approximately 30-36 months.
REC name
North West - Preston Research Ethics Committee
REC reference
13/NW/0887
Date of REC Opinion
12 Feb 2014
REC opinion
Further Information Favourable Opinion